Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	66
Overall Study	STARTED	Linaclotide IR 290 μg	66
Overall Study	STARTED	Linaclotide DR1 30 μg	67
Overall Study	STARTED	Linaclotide DR1 100 μg	67
Overall Study	STARTED	Linaclotide DR1 300 μg	67
Overall Study	STARTED	Linaclotide DR2 30 μg	67
Overall Study	STARTED	Linaclotide DR2 100 μg	66
Overall Study	STARTED	Linaclotide DR2 300 μg	66
Overall Study	COMPLETED	Placebo	58
Overall Study	COMPLETED	Linaclotide IR 290 μg	54
Overall Study	COMPLETED	Linaclotide DR1 30 μg	58
Overall Study	COMPLETED	Linaclotide DR1 100 μg	53
Overall Study	COMPLETED	Linaclotide DR1 300 μg	55
Overall Study	COMPLETED	Linaclotide DR2 30 μg	53
Overall Study	COMPLETED	Linaclotide DR2 100 μg	60
Overall Study	COMPLETED	Linaclotide DR2 300 μg	57
Overall Study	NOT COMPLETED	Placebo	8
Overall Study	NOT COMPLETED	Linaclotide IR 290 μg	12
Overall Study	NOT COMPLETED	Linaclotide DR1 30 μg	9
Overall Study	NOT COMPLETED	Linaclotide DR1 100 μg	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02559206/flow